Industry › BioTech

Press Releases

沛嘉醫療2022年總收入按年升83.7%

Apr 03, 2023 14:53 HKT/SGT

Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022

Apr 03, 2023 14:52 HKT/SGT

Eisai Enters Into Agreement With National Cancer Center to Collaborate on Investigator-Initiated Clinical Research for Anticancer Agent Tazemetostat Based on "Patient-Proposed Healthcare Services" System

Apr 03, 2023 12:06 HKT/SGT

Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition

Apr 03, 2023 12:00 HKT/SGT

Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition

Apr 03, 2023 11:53 HKT/SGT

エーザイ、抗がん剤タゼメトスタットについて、「患者申出療養」制度に基づく医師主導臨床研究への協力に関する契約を国立がん研究センターと締結

Apr 03, 2023 10:00 JST

中国生物制药（1177.HK）公布2022全年业绩

Mar 31, 2023 21:13 HKT/SGT

中國生物製藥（1177.HK）公佈2022全年業績

Mar 31, 2023 21:12 HKT/SGT

Sino Biopharm (1177.HK) Announces 2022 Annual Results

Mar 31, 2023 21:11 HKT/SGT

ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator

Mar 31, 2023 20:15 HKT/SGT

Eisai Presented New Analyses of Aria and QOL on Lecanemab in Clarity AD at the AD/PD 2023 Annual Meeting

Mar 31, 2023 15:51 HKT/SGT

Eisai: Additional Detailed Analyses from Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals

Mar 31, 2023 13:55 HKT/SGT

金活醫藥2022年經營穩中向好派末期股息每股2.47港仙

Mar 30, 2023 22:50 HKT/SGT

欧康维视公布2022年全年业绩

Mar 30, 2023 22:31 HKT/SGT

歐康維視公佈2022年全年業績

Mar 30, 2023 22:30 HKT/SGT

Ocumension Therapeutics Announces 2022 Annual Results

Mar 30, 2023 22:29 HKT/SGT

冠科美博（Apollomics Inc.）宣布完成和SPAC Maxpro合并，并在纳斯达克上市

Mar 30, 2023 20:31 HKT/SGT

冠科美博（Apollomics Inc.）宣佈完成和SPAC Maxpro合併，並在納斯達克上市

Mar 30, 2023 20:30 HKT/SGT

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq

Mar 30, 2023 20:29 HKT/SGT

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq

Mar 30, 2023 20:05 HKT/SGT